News Feed
Posts

Trace Genomics, a Stage 1 Ventures portfolio company, announced Tuesday that it has closed a Series A funding round for $13 million. The round, led by Stage 1 Ventures, brings the company’s total venture funding to over $19 million.

“Trace Genomics has developed a highly scalable software and analytics platform to quantify soil productivity and offer actionable insights never before captured. It has the opportunity to transform how we measure sustainable and regenerative farm management practices,” Stage 1 Ventures operating partner Joseph Pianelli said in a statement.

“The world is pretty open for us in terms of what we can impact moving forward,” said Diane Wu, the company’s CEO and a Forbes Under 30 alumnus. “Over 70 percent of decisions a soybean farmer makes is something we can impact with our technology.”

Additional information can be found in the Forbes article.